ACIU
Price
$2.29
Change
-$0.08 (-3.38%)
Updated
Apr 25, 6:59 PM EST
97 days until earnings call
JAZZ
Price
$107.43
Change
-$0.89 (-0.82%)
Updated
Apr 25, 6:59 PM EST
5 days until earnings call
Ad is loading...

Compare trend and price ACIU vs JAZZ

Header iconACIU vs JAZZ Comparison
Open Charts ACIU vs JAZZBanner chart's image
AC Immune SA
Price$2.29
Change-$0.08 (-3.38%)
Volume$71.19K
CapitalizationN/A
Jazz Pharmaceuticals
Price$107.43
Change-$0.89 (-0.82%)
Volume$220.11K
CapitalizationN/A
View a ticker or compare two or three
ACIU vs JAZZ Comparison Chart

Loading...

ACIUDaily Signal changed days agoGain/Loss if shorted
 
Show more...
JAZZDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ACIU vs. JAZZ commentary
Apr 26, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACIU is a Buy and JAZZ is a StrongSell.

COMPARISON
Comparison
Apr 26, 2024
Stock price -- (ACIU: $2.29 vs. JAZZ: $107.43)
Brand notoriety: ACIU and JAZZ are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACIU: 80% vs. JAZZ: 65%
Market capitalization -- ACIU: $226.48M vs. JAZZ: $6.7B
ACIU [@Biotechnology] is valued at $226.48M. JAZZ’s [@Biotechnology] market capitalization is $6.7B. The market cap for tickers in the [@Biotechnology] industry ranges from $562.44B to $0. The average market capitalization across the [@Biotechnology] industry is $2.55B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACIU’s FA Score shows that 0 FA rating(s) are green whileJAZZ’s FA Score has 0 green FA rating(s).

  • ACIU’s FA Score: 0 green, 5 red.
  • JAZZ’s FA Score: 0 green, 5 red.
According to our system of comparison, both ACIU and JAZZ are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACIU’s TA Score shows that 3 TA indicator(s) are bullish while JAZZ’s TA Score has 4 bullish TA indicator(s).

  • ACIU’s TA Score: 3 bullish, 3 bearish.
  • JAZZ’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ACIU is a better buy in the short-term than JAZZ.

Price Growth

ACIU (@Biotechnology) experienced а -3.78% price change this week, while JAZZ (@Biotechnology) price change was -1.68% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.76%. For the same industry, the average monthly price growth was -8.05%, and the average quarterly price growth was +1257.31%.

Reported Earning Dates

ACIU is expected to report earnings on Aug 01, 2024.

JAZZ is expected to report earnings on Aug 06, 2024.

Industries' Descriptions

@Biotechnology (-0.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ACIU with price predictions.
OPEN
A.I.dvisor published
a Summary for JAZZ with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
JAZZ($6.7B) has a higher market cap than ACIU($226M). JAZZ YTD gains are higher at: -12.659 vs. ACIU (-54.200).
ACIUJAZZACIU / JAZZ
Capitalization226M6.7B3%
EBITDAN/AN/A-
Gain YTD-54.200-12.659428%
P/E RatioN/A17.61-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
ACIU vs JAZZ: Fundamental Ratings
ACIU
JAZZ
OUTLOOK RATING
1..100
5953
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
65
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9666
PRICE GROWTH RATING
1..100
6579
P/E GROWTH RATING
1..100
8498
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ACIU's Valuation (53) in the Pharmaceuticals Major industry is in the same range as JAZZ (65) in the Pharmaceuticals Other industry. This means that ACIU’s stock grew similarly to JAZZ’s over the last 12 months.

ACIU's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as JAZZ (100) in the Pharmaceuticals Other industry. This means that ACIU’s stock grew similarly to JAZZ’s over the last 12 months.

JAZZ's SMR Rating (66) in the Pharmaceuticals Other industry is in the same range as ACIU (96) in the Pharmaceuticals Major industry. This means that JAZZ’s stock grew similarly to ACIU’s over the last 12 months.

ACIU's Price Growth Rating (65) in the Pharmaceuticals Major industry is in the same range as JAZZ (79) in the Pharmaceuticals Other industry. This means that ACIU’s stock grew similarly to JAZZ’s over the last 12 months.

ACIU's P/E Growth Rating (84) in the Pharmaceuticals Major industry is in the same range as JAZZ (98) in the Pharmaceuticals Other industry. This means that ACIU’s stock grew similarly to JAZZ’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACIUJAZZ
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
89%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 1 day ago
66%
Momentum
ODDS (%)
N/A
Bearish Trend 1 day ago
64%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
63%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
61%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
62%
Advances
ODDS (%)
N/A
Bullish Trend 8 days ago
63%
Declines
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
60%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
66%
Aroon
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
59%
View a ticker or compare two or three
Ad is loading...
ACIUDaily Signal changed days agoGain/Loss if shorted
 
Show more...
JAZZDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
UMAR32.00-0.09
-0.28%
Innovator S&P 500 Ultra Buffer ETF™ Mar
HFXI26.19-0.13
-0.49%
IQ FTSE International Eq Ccy Netrl ETF
LOUP44.04-0.24
-0.53%
Innovator Deepwater Frontier Tech ETF
DBEF40.18-0.25
-0.62%
Xtrackers MSCI EAFE Hedged Equity ETF
MDLV25.10-0.18
-0.69%
Morgan Dempsey Large Cap Value ETF

ACIU and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACIU has been loosely correlated with BDTX. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if ACIU jumps, then BDTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACIU
1D Price
Change %
ACIU100%
-3.38%
BDTX - ACIU
62%
Loosely correlated
+0.99%
SYRE - ACIU
51%
Loosely correlated
-1.58%
VKTX - ACIU
31%
Poorly correlated
+5.82%
FGEN - ACIU
30%
Poorly correlated
+3.63%
IPSC - ACIU
30%
Poorly correlated
+6.42%
More